174 related articles for article (PubMed ID: 3058232)
1. Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea.
Chitambar CR; Matthaeus WG; Antholine WE; Graff K; O'Brien WJ
Blood; 1988 Dec; 72(6):1930-6. PubMed ID: 3058232
[TBL] [Abstract][Full Text] [Related]
2. Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium.
Chitambar CR; Narasimhan J
Pathobiology; 1991; 59(1):3-10. PubMed ID: 1645976
[TBL] [Abstract][Full Text] [Related]
3. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
Chitambar CR; Zivkovic-Gilgenbach Z; Narasimhan J; Antholine WE
Cancer Res; 1990 Aug; 50(15):4468-72. PubMed ID: 2164439
[TBL] [Abstract][Full Text] [Related]
4. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
Ul-Haq R; Chitambar CR
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Chitambar CR; Narasimhan J; Guy J; Sem DS; O'Brien WJ
Cancer Res; 1991 Nov; 51(22):6199-201. PubMed ID: 1933878
[TBL] [Abstract][Full Text] [Related]
6. Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
Myette MS; Elford HL; Chitambar CR
Cancer Lett; 1998 Jul; 129(2):199-204. PubMed ID: 9719462
[TBL] [Abstract][Full Text] [Related]
7. Effect of gallium on the tyrosyl radical of the iron-dependent M2 subunit of ribonucleotide reductase.
Narasimhan J; Antholine WE; Chitambar CR
Biochem Pharmacol; 1992 Dec; 44(12):2403-8. PubMed ID: 1335254
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydroxyurea on cellular iron metabolism in human leukemic CCRF-CEM cells: changes in iron uptake and the regulation of transferrin receptor and ferritin gene expression following inhibition of DNA synthesis.
Chitambar CR; Wereley JP
Cancer Res; 1995 Oct; 55(19):4361-6. PubMed ID: 7671248
[TBL] [Abstract][Full Text] [Related]
9. Role of the M2 subunit of ribonucleotide reductase in regulation by hydroxyurea of the activity of the anti-HIV-1 agent 2',3'-dideoxyinosine.
Gao WY; Zhou BS; Johns DG; Mitsuya H; Yen Y
Biochem Pharmacol; 1998 Jul; 56(1):105-12. PubMed ID: 9698094
[TBL] [Abstract][Full Text] [Related]
10. Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.
Lundberg JH; Chitambar CR
Cancer Res; 1990 Oct; 50(20):6466-70. PubMed ID: 1698536
[TBL] [Abstract][Full Text] [Related]
11. Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells.
Chitambar CR; Sax D
Blood; 1992 Jul; 80(2):505-11. PubMed ID: 1627803
[TBL] [Abstract][Full Text] [Related]
12. Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.
Szekeres T; Fritzer M; Strobl H; Gharehbaghi K; Findenig G; Elford HL; Lhotka C; Schoen HJ; Jayaram HN
Blood; 1994 Dec; 84(12):4316-21. PubMed ID: 7994048
[TBL] [Abstract][Full Text] [Related]
13. Transferrin receptor-mediated suppression of in vitro hematopoiesis by transferrin-gallium.
Chitambar CR; Craig A; Ash RC
Exp Hematol; 1989 Jun; 17(5):418-22. PubMed ID: 2714421
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hemoglobin production by transferrin-gallium.
Chitambar CR; Zivkovic Z
Blood; 1987 Jan; 69(1):144-9. PubMed ID: 3790721
[TBL] [Abstract][Full Text] [Related]
15. Combination iron depletion therapy.
Taetle R; Honeysett JM; Bergeron R
J Natl Cancer Inst; 1989 Aug; 81(16):1229-35. PubMed ID: 2666676
[TBL] [Abstract][Full Text] [Related]
16. Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis.
Wright JA; Chan AK; Choy BK; Hurta RA; McClarty GA; Tagger AY
Biochem Cell Biol; 1990 Dec; 68(12):1364-71. PubMed ID: 2085432
[TBL] [Abstract][Full Text] [Related]
17. Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium.
Chitambar CR; Seligman PA
J Clin Invest; 1986 Dec; 78(6):1538-46. PubMed ID: 3465751
[TBL] [Abstract][Full Text] [Related]
18. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
[TBL] [Abstract][Full Text] [Related]
19. Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).
Heffeter P; Popovic-Bijelic A; Saiko P; Dornetshuber R; Jungwirth U; Voevodskaya N; Biglino D; Jakupec MA; Elbling L; Micksche M; Szekeres T; Keppler BK; Gräslund A; Berger W
Curr Cancer Drug Targets; 2009 Aug; 9(5):595-607. PubMed ID: 19508176
[TBL] [Abstract][Full Text] [Related]
20. Correlation between levels of ferritin and the iron-containing component of ribonucleotide reductase in hydroxyurea-sensitive, -resistant, and -revertant cell lines.
Hurta RA; Wright JA
Biochem Cell Biol; 1991 Sep; 69(9):635-42. PubMed ID: 1793565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
